Free Cash Flow CAGR:16.68%(TTM)
Free cash flow CAGR uses precomputed cash-flow statement history.
Over longer horizons, Free Cash Flow CAGR averages -11.60% over 3 years and -17.24% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Free cash flow CAGR measures how the company's cash generation has grown. FCF represents the cash available for dividends, buybacks, debt reduction, or reinvestment.
NRC Free Cash Flow CAGR Chart
National Research Corporation (NRC)
NRC Quarterly Free Cash Flow Growth (YoY)
Free Cash Flow growth vs the same quarter one year earlier, last 20 quarters.
NRC Free Cash Flow CAGR History
| Year | Start FCF | End FCF | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $19.18M | $15.74M | $-3.43M | -17.90% | -17.90% |
| 2024 | $22.33M | $19.18M | $-3.16M | -14.14% | -14.14% |
| 2023 | $26.43M | $22.33M | $-4.10M | -15.50% | -15.50% |
| 2022 | $40.83M | $26.43M | $-14.40M | -35.27% | -35.27% |
| 2021 | $36.65M | $40.83M | +$4.18M | +11.40% | +11.40% |
| 2020 | $36.26M | $36.65M | +$391.00K | +1.08% | +1.08% |
| 2019 | $33.88M | $36.26M | +$2.38M | +7.04% | +7.04% |
| 2018 | $23.27M | $33.88M | +$10.60M | +45.56% | +45.56% |
| 2017 | $22.87M | $23.27M | +$403.00K | +1.76% | +1.76% |
| 2016 | $18.95M | $22.87M | +$3.92M | +20.71% | +20.71% |
| 2015 | $23.70M | $18.95M | $-4.76M | -20.07% | -20.07% |
| 2014 | $17.13M | $23.70M | +$6.58M | +38.41% | +38.41% |
| 2013 | $16.78M | $17.13M | +$343.00K | +2.04% | +2.04% |
| 2012 | $15.67M | $16.78M | +$1.11M | +7.12% | +7.12% |
| 2011 | $13.06M | $15.67M | +$2.60M | +19.94% | +19.94% |
| 2010 | $10.76M | $13.06M | +$2.31M | +21.45% | +21.45% |
| 2009 | $12.36M | $10.76M | $-1.61M | -12.99% | -12.99% |
| 2008 | $12.61M | $12.36M | $-246.88K | -1.96% | -1.96% |
| 2007 | $5.36M | $12.61M | +$7.25M | +135.30% | +135.30% |
| 2006 | $7.10M | $5.36M | $-1.74M | -24.52% | -24.52% |
| 2005 | $5.75M | $7.10M | +$1.35M | +23.48% | +23.48% |
| 2004 | $6.58M | $5.75M | $-832.08K | -12.64% | -12.64% |
| 2003 | $2.75M | $6.58M | +$3.83M | +139.35% | +139.35% |
| 2002 | $1.54M | $2.75M | +$1.21M | +78.99% | +78.99% |
| 2001 | $-4.17M | $1.54M | +$5.71M | N/A | N/A |
| 2000 | $-1.40M | $-4.17M | $-2.77M | N/A | N/A |
| 1999 | $-3.80M | $-1.40M | +$2.40M | N/A | N/A |
| 1998 | $1.20M | $-3.80M | $-5.00M | -416.67% | N/A |
| 1997 | $6.00M | $1.20M | $-4.80M | -80.00% | -80.00% |
Quarterly Free Cash Flow: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $5.35M | -11.8% | +46.1% |
| Q4 2025 | $6.06M | -40.5% | +213.1% |
| Q3 2025 | $10.18M | — | +30.0% |
| Q2 2025 | -$4.15M | — | — |
| Q1 2025 | $3.66M | +89.1% | -53.7% |
| Q4 2024 | $1.94M | -75.3% | -75.6% |
| Q3 2024 | $7.83M | +415.9% | +46.4% |
| Q2 2024 | $1.52M | -80.8% | -66.3% |
| Q1 2024 | $7.90M | -0.5% | +73.5% |
| Q4 2023 | $7.94M | +48.5% | +29.3% |
| Q3 2023 | $5.35M | +19.0% | -11.9% |
| Q2 2023 | $4.50M | -1.3% | -47.0% |
| Q1 2023 | $4.55M | -25.8% | -20.8% |
| Q4 2022 | $6.14M | +1.2% | -40.7% |
| Q3 2022 | $6.07M | -28.4% | -21.3% |
| Q2 2022 | $8.48M | +47.5% | -11.6% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green